| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8448672 | European Journal of Cancer | 2008 | 8 Pages |
Abstract
Trabectedin, at pharmacologically appropriated concentrations, harbours a significant in vitro radiosensitising effect and induces cell cycle changes and apoptosis in several human cancer cell lines. Further studies to define the clinical potential of the combination of trabectedin and radiotherapy are needed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jesús Romero, Irma Zapata, SofÃa Córdoba, José MarÃa Jimeno, José Antonio López-MartÃn, Juan Carlos Tercero, Alejandro De La Torre, Juan Antonio Vargas, Rafael Molerón, Ricardo Sánchez-Prieto,